Position in ALXO
as of Dec 31, 2025
· filed Jan 29, 2026
Position Value
$1,842,961
-$954,411 QoQ
Shares Held
1,630,940
+6.7% QoQ
Ownership
1.21%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Sep 2020
22 quarters on record
Voting authority
Sole 0.ToString("F0")%
Shared 12.157283529743584.ToString("F0")%
None 87.84271647025642.ToString("F0")%
Common Shares in ALXO Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Dec 31, 2025VANGUARD GROUP INC holds $65,710,461,655 across 449 Biotechnology names. ALXO ranks #323 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
24,105,823 | $10,928,615,912 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
9,075,153 | $7,004,838,343 | |
| 3 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
13,553,932 | $5,389,721,058 | |
| 4 | INSM |
INSMED Inc
|
21,076,344 | $3,668,126,907 | |
| 5 | INCY |
Incyte Corp
|
19,911,434 | $1,966,652,333 | |
| 6 | RVMD |
Revolution Medicines, Inc.
|
16,719,886 | $1,331,738,919 | |
| 7 | IONS |
Ionis Pharmaceuticals Inc
|
16,440,459 | $1,300,604,709 | |
| 8 | BBIO |
BridgeBio Pharma, Inc.
|
16,862,691 | $1,289,827,232 |
All Filings in ALXO
Export CSV
22 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2025-12-31 | $1,842,961 | 1,630,940 | Shares | Sole | 2026-01-29 | |
| 2025-09-30 | $2,797,372 | 1,528,619 | Shares | Defined | 2025-11-07 | |
| 2025-06-30 | $664,334 | 1,600,808 | Shares | Sole | 2025-08-11 | |
| 2025-03-31 | $1,145,025 | 1,837,923 | Shares | Defined | 2025-05-09 | |
| 2024-12-31 | $3,151,291 | 1,887,002 | Shares | Sole | 2025-02-11 | |
| 2024-09-30 | $3,429,921 | 1,884,573 | Shares | Defined | 2024-11-13 | |
| 2024-06-30 | $10,415,303 | 1,727,248 | Shares | Defined | 2024-08-13 | |
| 2024-03-31 | $17,466,072 | 1,566,464 | Shares | Defined | 2024-05-10 | |
| 2023-12-31 | $22,370,869 | 1,502,409 | Shares | Defined | 2024-03-11 | |
| 2023-09-30 | $4,839,532 | 1,008,236 | Shares | Sole | 2023-12-18 | |
| 2023-06-30 | $7,559,474 | 1,006,588 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $4,680,634 | 1,035,539 | Shares | Sole | 2023-07-14 | |
| 2022-12-31 | $16,063,106 | 1,425,298 | Shares | Defined | 2023-02-10 | |
| 2022-09-30 | $13,503,354 | 1,411,009 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $10,717,120 | 1,324,737 | Shares | Sole | 2022-08-12 | |
| 2022-03-31 | $28,318,584 | 1,675,656 | Shares | Sole | 2022-05-13 | |
| 2021-12-31 | $36,705,648 | 1,708,034 | Shares | Sole | 2022-02-14 | |
| 2021-09-30 | $124,049,936 | 1,679,528 | Shares | Sole | 2021-11-12 | |
| 2021-06-30 | $84,738,578 | 1,549,718 | Shares | Defined | 2021-08-13 | |
| 2021-03-31 | $100,073,142 | 1,357,108 | Shares | Defined | 2021-05-14 | |
| 2020-12-31 | $76,137,183 | 883,262 | Shares | Defined | 2021-02-12 | |
| 2020-09-30 | $24,356,715 | 645,382 | Shares | Sole | 2020-11-16 | |
| No filing history on record for this holder in this stock. | ||||||